DiaMedica Therapeutics Inc.
DMAC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $219 | $92 | $42 | $77 |
| - Cash | $3 | $5 | $5 | $5 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $217 | $88 | $38 | $73 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$27 | -$21 | -$14 | -$14 |
| % Margin | – | – | – | – |
| Net Income | -$24 | -$19 | -$14 | -$14 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.6 | -0.6 | -0.52 | -0.65 |
| % Growth | 0% | -15.4% | 20% | – |
| Operating Cash Flow | -$22 | -$19 | -$12 | -$12 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$22 | -$19 | -$12 | -$12 |